Preparation of Biodegradable Polymer Nanospheres Containing Manganese Porphyrin (Mn-Porphyrin)

[1]  F. Ito.  Optimization of a simple technique for preparation of monodisperse poly(lactide-co-glycolide) nanospheres , 2016, Journal of Nanoparticle Research.

[2]  H. Kawakami,et al.  Facile technique for the preparation of monodispersed biodegradable polymer nanospheres using a solvent evaporation method , 2015 .

[3]  H. Kawakami,et al.  Dermal administration of manganese porphyrin by iontophoresis. , 2014, Materials science & engineering. C, Materials for biological applications.

[4]  K. Makino,et al.  Preparation of (hydrophilic) INZ/PLGA particles (microcapsules) employing a unique frozen water phase — investigation of optimal formulation , 2014 .

[5]  H. Kawakami,et al.  Possibility for the development of cosmetics with PLGA nanospheres , 2013, Drug development and industrial pharmacy.

[6]  H. Kawakami,et al.  Optimized preparation of biodegradable polymer particles encapsulating low-molecular-weight hydrophilic drugs , 2012 .

[7]  D. S. St. Clair,et al.  Manganese superoxide dismutase, MnSOD and its mimics. , 2012, Biochimica et biophysica acta.

[8]  H. Kawakami,et al.  Technique to encapsulate a low molecular weight hydrophilic drug in biodegradable polymer particles in a liquid–liquid system , 2011 .

[9]  Y. Uchida,et al.  Facile technique for preparing organic–inorganic composite particles: Monodisperse poly(lactide-co-glycolide) (PLGA) particles having silica nanoparticles on the surface , 2010 .

[10]  H. Kawakami,et al.  Control of drug loading efficiency and drug release behavior in preparation of hydrophilic-drug-containing monodisperse PLGA microspheres , 2010, Journal of materials science. Materials in medicine.

[11]  H. Kawakami,et al.  Protective effects of the complex between manganese porphyrins and catalase-poly(ethylene glycol) conjugates against hepatic ischemia/reperfusion injury in vivo. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[12]  H. Kawakami,et al.  Study of types and mixture ratio of organic solvent used to dissolve polymers for preparation of drug-containing PLGA microspheres , 2009 .

[13]  H. Kawakami,et al.  Preparation and properties of PLGA microspheres containing hydrophilic drugs by the SPG (shirasu porous glass) membrane emulsification technique. , 2008, Colloids and surfaces. B, Biointerfaces.

[14]  Robert Langer,et al.  Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticles , 2008, Proceedings of the National Academy of Sciences.

[15]  Kiyoshi Kanamura,et al.  Effect of polyethylene glycol on preparation of rifampicin-loaded PLGA microspheres with membrane emulsification technique. , 2008, Colloids and surfaces. B, Biointerfaces.

[16]  K. Owzar,et al.  Comparison of two Mn porphyrin-based mimics of superoxide dismutase in pulmonary radioprotection. , 2008, Free radical biology & medicine.

[17]  K. Makino,et al.  Factors affecting the loading efficiency of water-soluble drugs in PLGA microspheres. , 2008, Colloids and surfaces. B, Biointerfaces.

[18]  K. Makino,et al.  Incorporation of water-soluble drugs in PLGA microspheres. , 2007, Colloids and surfaces. B, Biointerfaces.

[19]  H. Kawakami,et al.  Superoxide dismutase as a target enzyme for Fe-porphyrin-induced cell death. , 2007, Journal of inorganic biochemistry.

[20]  K. Makino,et al.  Preparation and properties of monodispersed rifampicin-loaded poly(lactide-co-glycolide) microspheres. , 2004, Colloids and surfaces. B, Biointerfaces.

[21]  H. Kawakami,et al.  Design of metalloporphyrin-carbohydrate conjugates for a new superoxide dismutase mimic with cellular recognition. , 2004, Bioconjugate chemistry.

[22]  M. Muhammed,et al.  Mathematical modelling on the controlled-release of indomethacin-encapsulated poly(lactic acid-co-ethylene oxide) nanospheres , 2004 .

[23]  M. Karjalainen,et al.  Improved entrapment efficiency of hydrophilic drug substance during nanoprecipitation of poly(I)lactide nanoparticles , 2004, AAPS PharmSciTech.

[24]  Cory Berkland,et al.  Precise control of PLG microsphere size provides enhanced control of drug release rate. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[25]  R. A. Jain,et al.  The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. , 2000, Biomaterials.

[26]  Y. Kawashima,et al.  Properties of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[27]  I. Fridovich,et al.  The Ortho Effect Makes Manganese(III)Meso-Tetrakis(N-Methylpyridinium-2-yl)Porphyrin a Powerful and Potentially Useful Superoxide Dismutase Mimic* , 1998, The Journal of Biological Chemistry.

[28]  O'donnell,et al.  Preparation of microspheres by the solvent evaporation technique. , 1997, Advanced drug delivery reviews.

[29]  M. Shive,et al.  Biodegradation and biocompatibility of PLA and PLGA microspheres , 1997 .

[30]  T. Kondo,et al.  Preparation of Poly(D,L‐lactide) and Copoly(lactide‐glycolide) Microspheres of Uniform Size , 1996, The Journal of pharmacy and pharmacology.

[31]  H. Okada,et al.  Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: influence of molecular weight and copolymer ratio of polymer. , 1988, Chemical & pharmaceutical bulletin.

[32]  T Yashiki,et al.  A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid. , 1988, Chemical & pharmaceutical bulletin.

[33]  Nicholas A. Peppas,et al.  A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs , 1987 .

[34]  Nicholas A. Peppas,et al.  A simple equation for description of solute release II. Fickian and anomalous release from swellable devices , 1987 .

[35]  H. Kawakami,et al.  Mn-porphyrin derivatives as an antioxidant for medical devices. , 1999, Journal of biomaterials science. Polymer edition.